ZYFLO is a Oral Tablet in the Human Prescription Drug category. It is labeled and distributed by Chiesi Usa, Inc.. The primary component is Zileuton.
| Product ID | 10122-901_2ca0eba1-1472-455f-95d2-d96cf271565e |
| NDC | 10122-901 |
| Product Type | Human Prescription Drug |
| Proprietary Name | ZYFLO |
| Generic Name | Zileuton |
| Dosage Form | Tablet |
| Route of Administration | ORAL |
| Marketing Start Date | 1996-12-06 |
| Marketing Category | NDA / NDA |
| Application Number | NDA020471 |
| Labeler Name | Chiesi USA, Inc. |
| Substance Name | ZILEUTON |
| Active Ingredient Strength | 600 mg/1 |
| Pharm Classes | 5-Lipoxygenase Inhibitors [MoA],Decreased Leukotriene Production [PE],5-Lipoxygenase Inhibitor [EPC] |
| NDC Exclude Flag | N |
| Listing Certified Through | 2019-12-31 |
| Marketing Start Date | 1996-12-06 |
| NDC Exclude Flag | N |
| Sample Package? | N |
| Marketing Category | NDA |
| Application Number | NDA020471 |
| Product Type | HUMAN PRESCRIPTION DRUG |
| Billing Unit | EA |
| Marketing Start Date | 1996-12-06 |
| Marketing Category | NDA |
| Application Number | NDA020471 |
| Product Type | HUMAN PRESCRIPTION DRUG |
| Marketing Start Date | 1996-12-06 |
| Marketing End Date | 2011-07-12 |
| Ingredient | Strength |
|---|---|
| ZILEUTON | 600 mg/1 |
| SPL SET ID: | aee65202-fddb-497f-9f11-17cc727cb157 |
| Manufacturer | |
| UNII | |
| RxNorm Concept Unique ID - RxCUI |
| NDC | Brand Name | Generic Name |
|---|---|---|
| 10122-901 | ZYFLO | zileuton |
| 31722-044 | Zileuton | Zileuton |
| 49884-723 | Zileuton | zileuton |
| 64380-189 | Zileuton | zileuton |
| 64980-206 | Zileuton | Zileuton |
| 66993-485 | Zileuton | Zileuton |
| 68180-169 | ZILEUTON | Zileuton |
| 69339-130 | Zileuton | zileuton |
| 10122-902 | ZYFLO CR | zileuton |
Mark Image Registration | Serial | Company Trademark Application Date |
|---|---|
![]() ZYFLO 75179009 2157636 Live/Registered |
CHIESI USA, INC. 1996-10-09 |